Reneuron (OTCPK:RNUGF) has seen enough in a phase II study of its lead candidate, the stroke stem cell therapy ReN001, to move it forward. But the data were not as emphatic as they might have been, so ...

Surviving a stroke represents a significant health victory, but many survivors don’t realize they’ve entered a high-risk category for experiencing another event. Understanding why stroke lightning can ...

When administered soon after the onset of acute ischemic stroke, current approved treatments for the condition can dramatically improve patient outcomes. However, not all patients are cured, and ...

DALLAS, October 27, 2022 — The American Heart Association, the world’s leading voluntary organization focused on heart and brain health for all, is launching a two-year initiative to expand and ...